<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1362964</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2024.1362964</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>In silico</italic> models of the macromolecular Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex</article-title>
<alt-title alt-title-type="left-running-head">Stary-Weinzinger</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2024.1362964">10.3389/fphys.2024.1362964</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Stary-Weinzinger</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/12168/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff>
<institution>Division of Pharmacology and Toxicology</institution>, <institution>Department of Pharmaceutical Sciences</institution>, <institution>University of Vienna</institution>, <addr-line>Vienna</addr-line>, <country>Austria</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1778826/overview">Meng Cui</ext-link>, Northeastern University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/607507/overview">Jerome Montnach</ext-link>, INSERM U1087 Institut du Thorax, France</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/44788/overview">Peter M. Kekenes-Huskey</ext-link>, Loyola University Chicago, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Anna Stary-Weinzinger, <email>anna.stary@univie.ac.at</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1362964</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Stary-Weinzinger.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Stary-Weinzinger</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>In cardiac cells, the expression of the cardiac voltage-gated Na<sup>&#x2b;</sup> channel (Na<sub>V</sub>1.5) is reciprocally regulated with the inward rectifying K<sup>&#x2b;</sup> channel (K<sub>IR</sub>2.1). These channels can form macromolecular complexes that pre-assemble early during forward trafficking (transport to the cell membrane). In this study, we present <italic>in silico</italic> 3D models of Na<sub>V</sub>1.5-K<sub>IR</sub>2.1, generated by rigid-body protein-protein docking programs and deep learning-based AlphaFold-Multimer software. Modeling revealed that the two channels could physically interact with each other along the entire transmembrane region. Structural mapping of disease-associated mutations revealed a hotspot at this interface with several trafficking-deficient variants in close proximity. Thus, examining the role of disease-causing variants is important not only in isolated channels but also in the context of macromolecular complexes. These findings may contribute to a better understanding of the life-threatening cardiovascular diseases underlying K<sub>IR</sub>2.1 and Na<sub>V</sub>1.5 malfunctions.</p>
</abstract>
<kwd-group>
<kwd>Nav1.5</kwd>
<kwd>KIR2.1</kwd>
<kwd>protein-protein interactions</kwd>
<kwd>disease hotspot</kwd>
<kwd>trafficking</kwd>
<kwd>channelosomes</kwd>
</kwd-group>
<contract-num rid="cn001">W1232</contract-num>
<contract-sponsor id="cn001">Austrian Science Fund<named-content content-type="fundref-id">10.13039/501100002428</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Membrane Physiology and Membrane Biophysics</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Milstein et al. showed that the expression of the cardiac voltage-gated Na<sup>&#x2b;</sup> channel (Na<sub>V</sub>1.5, encoded by the <italic>SCNA5</italic> gene, I<sub>Na</sub> current) is reciprocally regulated by the inward rectifying K<sup>&#x2b;</sup> channels (K<sub>IR</sub>2.1, encoded by the <italic>KCNJ2</italic> gene, I<sub>K1</sub> current) in cardiac cells (<xref ref-type="bibr" rid="B22">Milstein et al., 2012</xref>). Both ion channels play key roles in cardiac excitability. Rapid depolarization of the membrane potential is mediated by Na<sub>V</sub>1.5, which allows an influx of positively charged Na<sup>&#x2b;</sup> ions, resulting in a rapid upstroke of the cardiac action potential. On the other hand, K<sub>IR</sub>2.1 is responsible for shaping the initial depolarization, final repolarization, and resting phases of the ventricular action potential (<xref ref-type="bibr" rid="B15">Ibarra et al., 1991</xref>). Consequently, these two channels are the most important ionic currents that control ventricular excitability. The essential role of both ion channels is further emphasized by the fact that dysfunction is associated with a high risk of arrhythmias and sudden cardiac death (<xref ref-type="bibr" rid="B1">Abriel, 2007</xref>; <xref ref-type="bibr" rid="B4">Cui et al., 2021</xref>; <xref ref-type="bibr" rid="B30">Reilly and Eckhardt, 2021</xref>; <xref ref-type="bibr" rid="B10">Hager et al., 2022</xref>).</p>
<p>The functional interaction between <italic>I</italic>
<sub>K1</sub> and <italic>I</italic>
<sub>Na</sub> is indirectly mediated via voltage dependence; however, increasing evidence suggests a direct interaction between these two channels. Moreover, K<sub>IR</sub>2.1 expression has been shown to increase the expression of Na<sub>V</sub>1.5 channels and <italic>vice versa</italic> (<xref ref-type="bibr" rid="B22">Milstein et al., 2012</xref>; <xref ref-type="bibr" rid="B35">Utrilla et al., 2017</xref>). A study by <xref ref-type="bibr" rid="B29">Ponce-Balbuena et al. (2018)</xref> revealed that the macromolecular complex Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 preassembles early in the forward trafficking pathway, with important implications for the mechanisms of inherited arrhythmias. Using a trafficking-deficient K<sub>IR</sub>2.1 mutant that causes the rare channelopathy Andersen-Tawil Syndrome (ATS1), the authors revealed mutual impairment in the forward trafficking of wild-type (WT) Na<sub>V</sub>1.5 channels. The potential reduction in I<sub>Na</sub> due to the reduction in I<sub>K1</sub> leads to the breakdown of the macromolecular complex between the two channels and contributes to the susceptibility of patients with ATS1 (<xref ref-type="bibr" rid="B23">Moreno-Manuel et al., 2023</xref>). Similarly, the trafficking of defective Na<sub>V</sub>1.5 mutants that leads to the rare Brugada syndrome (BrS) can negatively affect I<sub>K1</sub> by trapping cardiac K<sub>IR</sub>2.1/2.2 channels, contributing to the pathogenesis of arrhythmias (<xref ref-type="bibr" rid="B27">P&#xe9;rez-Hern&#xe1;ndez et al., 2018</xref>). While an increasing number of studies have underscored the physiological importance of the Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex, very little is known about the precise molecular nature of the macromolecular complex. CaMKII inhibition precludes the interaction between Na<sub>v</sub>1.5 and K<sub>IR</sub>2.1 channels (<xref ref-type="bibr" rid="B27">P&#xe9;rez-Hern&#xe1;ndez et al., 2018</xref>). Furthermore, inhibition of the 14-3-3 proteins reduces the co-expression of I<sub>Na</sub> and I<sub>K1</sub> currents without abolishing their interaction. Proximity ligation assay studies revealed the close proximity of Na<sub>V</sub>1.5 and K<sub>IR</sub>2.1 proteins in the membrane of ventricular myocytes (&#x3c;40&#xa0;nm apart) (<xref ref-type="bibr" rid="B35">Utrilla et al., 2017</xref>). Furthermore, both ion channels have been shown to co-immunoprecipitate in forward and reverse co-immunoprecipitations, emphasizing their direct interaction. However, only a subset of channels is presumed to co-assemble into macromolecular complexes known as channelosomes (<xref ref-type="bibr" rid="B22">Milstein et al., 2012</xref>; <xref ref-type="bibr" rid="B29">Ponce-Balbuena et al., 2018</xref>). Despite extensive analyses of the physiological importance of macromolecular complexes (for a recent review, see (<xref ref-type="bibr" rid="B30">Reilly and Eckhardt, 2021</xref>), structural insights into the Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 macromolecular complex are still lacking. The 3D structures of isolated human K<sub>IR</sub>2.1 (<xref ref-type="bibr" rid="B8">Fernandes et al., 2022</xref>) and human Na<sub>V</sub>1.5, channels (<xref ref-type="bibr" rid="B17">Jiang et al., 2020</xref>; <xref ref-type="bibr" rid="B21">Li et al., 2021</xref>) were solved at the atomic level using cryo-electron microscopy (cryo-EM). Na<sub>V</sub>1.5 channels consist of four homologous transmembrane domains (DI&#x2013;DIV) linked by three intracellular loops containing six segments (S1&#x2013;S6). Cryo-EM structures provide detailed insights into the voltage-dependent activation, inactivation gates, ion selectivity filters, and drug blocks of several antiarrhythmic drugs (<xref ref-type="bibr" rid="B24">Noreng et al., 2021</xref>). Only one cryo-EM structure of the human K<sub>IR</sub>2.1 channel has been published in a closed conformation (<xref ref-type="bibr" rid="B8">Fernandes et al., 2022</xref>). K<sub>IR</sub>2.1, which can form homotetrameric and heterotetrameric pores, consists of a canonical pore-forming transmembrane domain (TMD) with two transmembrane helices (M1 and M2) separated by a K<sup>&#x2b;</sup> selectivity filter, and a large cytoplasmic domain (CTD) containing N- and C-termini (<xref ref-type="bibr" rid="B11">Hibino et al., 2010</xref>).</p>
<p>These atomic-resolution structures make it possible to use computational methods to investigate the physical interactions between the two channels. In this study, we report <italic>in silico</italic> 3D models of macromolecular Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complexes, generated by rigid-body protein-protein docking programs and a deep learning-based AlphaFold-Multimer.</p>
</sec>
<sec sec-type="results|discussion" id="s2">
<title>2 Results and discussion</title>
<sec id="s2-1">
<title>2.1 Close physical interactions between Na<sub>V</sub>1.5 and K<sub>IR</sub>2.1 in the closed conformation</title>
<p>The prediction of protein-protein interactions (PPIs) is a challenging process, both experimentally and computationally, and the success rates of these computational methods are still relatively low (<xref ref-type="bibr" rid="B39">Vreven et al., 2015</xref>). Considering the limitations and challenges of computational methods (for a recent review, see (<xref ref-type="bibr" rid="B37">Vakser, 2020</xref>), we combined rigid-body docking strategies and deep learning-based methods for obtaining the most realistically possible insights into the macromolecular Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex. Three <italic>in silico</italic> programs were selected based on their ability to handle large proteins. As detailed in the Methods section, two rigid-body docking programs, FRODOCK (<xref ref-type="bibr" rid="B9">Garzon et al., 2009</xref>), ClusPro (<xref ref-type="bibr" rid="B18">Kozakov et al., 2017</xref>), and the AlphaFold-Multimer (v3) deep learning tool (<xref ref-type="bibr" rid="B7">Evans et al., 2021</xref>), trained for PPI, were used to predict 3D interactions between Na<sub>V</sub>1.5 and K<sub>IR</sub>2.1.</p>
<p>Based on the experimental finding that channels assemble early during forward trafficking (<xref ref-type="bibr" rid="B29">Ponce-Balbuena et al., 2018</xref>), the 3D coordinates of the channels in closed conformations were chosen as the starting points for modeling. This is based on the assumption that in order to transiently open, Na<sub>V</sub> channels require depolarizing conditions, not present during forward trafficking. Further, all experimental 3D structures of eukaryotic K<sub>IR</sub> channels have been obtained in closed state conformations, unless gating modifying mutations have been introduced, suggesting that this state is energetically favored and might thus represent a plausible trafficking conformation.</p>
<p>The cryo-EM structure of the full-length human Na<sub>V</sub>1.5 channel was obtained at 0&#xa0;mV, with the voltage sensor modules in the &#x201c;up-state,&#x201d; and the intracellular gate in a constricted, presumably inactivated state, inhibited by quinidine (<xref ref-type="bibr" rid="B21">Li et al., 2021</xref>). The cryo-EM structure of the human K<sub>IR</sub>2.1 channel represents a fully closed state with the cytoplasmic domain disengaged from the transmembrane domain and the helix bundle-crossing region restricted by two hydrophobic residues (<xref ref-type="bibr" rid="B8">Fernandes et al., 2022</xref>).</p>
<p>Both rigid-body docking programs predicted a favorable interface between the two channels over the entire transmembrane region (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Modeled interactions between Na<sub>V</sub>1.5 and K<sub>IR</sub>2.1. <bold>(A)</bold> Surface representation of the best predicted Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex from ClusPro in top view. <bold>(B)</bold> Surface representation of the best-predicted Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex from FRODOCK in top view. <bold>(C)</bold> Surface representation of the best-predicted Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex from AlphaFold-Multimer in top view. <bold>(D&#x2013;F)</bold> Consensus interface between helices DII-S1 from the VSD of Na<sub>V</sub>1.5 is shown as a green drawing with residues containing atoms within 6&#xa0;&#xc5; shown as sticks. The distances between the selected residue pairs are shown. D, predicted interactions from ClusPro; E, predicted interactions from FRODOCK; and F, predicted interactions from AlphaFold-Multimer. Na<sub>V</sub>1.5 is shown in green, while two subunits of K<sub>IR</sub>2.1 are colored in light orange, and the opposing subunits are colored in violet.</p>
</caption>
<graphic xlink:href="fphys-15-1362964-g001.tif"/>
</fig>
<p>Extensive interactions were observed between helices S3 and S4 of VSD-III, helices III-S5, and the outer P-helical segment of domain III (<xref ref-type="fig" rid="F1">Figures 1A, B</xref>; <xref ref-type="sec" rid="s9">Supplementary Figure S1A</xref>). The overall interface area was large, with values of up to 3652.4 &#xc5;<sup>2</sup> (see <xref ref-type="table" rid="T1">Table 1</xref>). Most intermolecular contacts between Na<sub>V</sub>1.5 and K<sub>IR</sub>2.1 were hydrophobic in nature. This was predictable because the majority of the interface lies in the membrane-spanning region. In addition, 21 hydrophilic contacts (hydrogen bonds and salt bridges) were identified in the best model obtained using ClusPro (<xref ref-type="table" rid="T1">Table 1</xref>; <xref ref-type="sec" rid="s9">Supplementary Table S1</xref>. Interface residues within 5.5&#xa0;&#xc5; predicted by FRODOCK are listed in <xref ref-type="sec" rid="s9">Supplementary Table S2</xref>. Extensive contacts between Na<sub>V</sub>1.5 and K<sub>IR</sub>2.1 might also be formed in the cytoplasmic domain. Unfortunately, these regions, particularly in the Na<sub>V</sub>1.5 channel, lack a cryo-EM structure and cannot be reliably modeled with AlphaFold (see <xref ref-type="sec" rid="s9">Supplementary Figure S3</xref>), precluding further analysis of putative intracellular contacts.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Interface analysis; abbreviations: C, charged; P, polar; A, apolar.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th colspan="4" align="center">PISA-PDBe</th>
<th colspan="3" align="center">Prodigy</th>
</tr>
<tr>
<td align="left">Model</td>
<td align="left">Interface area &#xc5;<sup>2</sup>
</td>
<td align="left">&#x394;G Kcal/mol<sup>-1</sup>
</td>
<td align="left">Hydrogen bonds</td>
<td align="left">Salt bridges</td>
<td align="left">&#x394;G Kcal/mol<sup>-1</sup>
</td>
<td align="left">Intermolecular contacts C-C/C-P/P-P/P-A/A-A</td>
<td align="left">Non-interacting surface (%) C/A</td>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">ClusPro2.0</td>
<td align="left">3594.9</td>
<td align="left">&#x2212;89.1</td>
<td align="left">16</td>
<td align="left">6</td>
<td align="left">&#x2212;15.2</td>
<td align="left">9/15/34/2/33/137</td>
<td align="left">22.67/48.02</td>
</tr>
<tr>
<td align="left">FRODOCK</td>
<td align="left">3652.4</td>
<td align="left">&#x2212;57.6</td>
<td align="left">2</td>
<td align="left">1</td>
<td align="left">&#x2212;14.5</td>
<td align="left">2/5/22/1/40/157</td>
<td align="left">22.4/51.33</td>
</tr>
<tr>
<td align="left">AlphaFold-Multimer v3</td>
<td align="left">457.7</td>
<td align="left">&#x2212;8.7</td>
<td align="left">1</td>
<td align="left">0</td>
<td align="left">&#x2212;5.9</td>
<td align="left">1/1/12/0/3/14</td>
<td align="left">24.82/46.22</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-2">
<title>2.2 State-dependent changes in the Na<sub>V</sub>1.5 - K<sub>IR</sub>2.1 interface</title>
<p>In contrast to rigid docking programs, in which the conformation of the interaction partners can be actively chosen, the conformations modeled by AlphaFold-Multimer cannot be selected <italic>a priori</italic>. The AlphaFold-Multimer consistently models the K<sup>&#x2b;</sup> channel in the open-channel state, with an engaged cytoplasmic domain (<xref ref-type="fig" rid="F2">Figures 2A, B</xref>; <xref ref-type="sec" rid="s9">Supplementary Figure S1B</xref>). <xref ref-type="sec" rid="s9">Supplementary Figure S1A</xref> show the structural superposition of Na<sub>V</sub>1.5 and K<sub>IR</sub>2.1 channels with their respective cryo-EM structures.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>putative open-state model of K<sub>IR</sub>2.1. <bold>(A)</bold> Representation of the open-state K<sub>IR</sub>2.1 model from AlphaFold in side view; <bold>(B)</bold>, magnification of the HBC gate, viewed from the bottom, with closed-state constricting residues I178 and M182 shown as sticks.</p>
</caption>
<graphic xlink:href="fphys-15-1362964-g002.tif"/>
</fig>
<p>Although the AlphaFold Multimer was run in &#x2018;no template mode&#x2019;, it modeled the conformation of K<sub>IR</sub>2.1, highly similar to the open, conductive state of K<sub>IR</sub>2.2 (<xref ref-type="bibr" rid="B44">Zangerl-Plessl et al., 2019</xref>) with an overall RMSD of 1.47&#xa0;&#xc5; between the two structures (see <xref ref-type="sec" rid="s9">Supplementary Figure S1C</xref>). In the modeled structure, both the interfacial and tether helices folded, and the hydrophobic residues I178 and M182 did not restrict ion flux through the HBC gate, as seen in the closed cryo-EM state (<xref ref-type="fig" rid="F2">Figure 2B</xref>). This was unexpected given the lack of the main activatory ligand PIP<sub>2</sub> or anionic lipids, which are crucial for channel activation gating (<xref ref-type="bibr" rid="B11">Hibino et al., 2010</xref>; <xref ref-type="bibr" rid="B20">Lee et al., 2016</xref>).</p>
<p>In this gating state, the predicted interface between Na<sub>V</sub>1.5 and K<sub>IR</sub>2.1 was much smaller, with a surface area of 457.7 2&#xa0;&#xc5; (<xref ref-type="table" rid="T1">Table 1</xref>). This suggests that PPI between the two channels is highly sensitive to their gating states. Remarkably, however, a favorable interface between the voltage sensor domains (VSDs) of domain II and the transmembrane helix 1 (TM1) of the K<sub>IR</sub>2.1 channel was observed in both the rigid-body closed-state complex and AlphaFold-predicted open-state models (<xref ref-type="fig" rid="F1">Figures 1C,F</xref>), suggesting state-independence of this interface, when considering open vs. closed K<sub>IR</sub>2.1 states. The movement of TM1 during K<sub>IR</sub>2.1 channel gating is negligible, as can be seen, when comparing the closed and open state structure models respectively (<xref ref-type="sec" rid="s9">Supplementary Figure S1B</xref>). The situation is less clear for voltage sensor movement of Na<sub>V</sub>1.5. Our knowledge about VSD movement in Na<sub>V</sub> channels is far from complete, but a cryo-EM-structure of a toxin induced deactivated state of a Na<sub>V</sub>1.7 VSD with a resolution of 4.2&#xa0;&#xc5; is available (<xref ref-type="bibr" rid="B41">Xu et al., 2019</xref>). This structure suggests that helices S1-S3 undergo rigid body shifts of &#x223c; 3&#xc5;, while the S4 helix translates &#x223c; 10&#xa0;&#xc5; during gating. Assuming that similar structural arrangements occur during normal electromechanical coupling in Na<sub>V</sub>1.5 voltage sensor deactivation would influence KIR2.1 interaction. A more detailed understanding will require extensive further studies, beyond the scope of the current work.</p>
<p>As shown in <xref ref-type="fig" rid="F1">Figures 1D&#x2013;F</xref>, the interactions at this interface were hydrophobic. The AlphaFold model is colored according to the per-residue model confidence score (pLDDT), which provides a measure of the confidence of the respective residue (see <xref ref-type="sec" rid="s9">Supplementary Figure S3</xref> for the complete structure). All residues at the interface (DII-S1 helix) had high to very high confidence scores.</p>
<p>While, the region of Na<sub>V</sub>1.5 predicted to interact with K<sub>IR</sub>2.1 was modelled in a state very similar to</p>
<p>The available cryo-EM structure, with an overall RMSD of 1.45&#xa0;&#xc5; between the two structures (<xref ref-type="fig" rid="F3">Figure 3 A, B</xref>). However, deviations at the intracellular side of the transmembrane region (e.g., DII-S4-S5 helix, as shown in <xref ref-type="fig" rid="F3">Figure 3B</xref>) are observed. The voltage sensor of domain II is predicted in the &#x201c;up-state&#x201d; in both the cryo-EM structure and the Alphafold model, however R814 is positioned slightly below the hydrophobic constriction site (HCS) in the latter. While the pLDDT score in helix DII-S4 is indicating high model quality (&#x3e;70), this is not the case for DII-S4-S5, with low pLDDT scores (&#x223c;65), indicating low reliability. Thus, these deviations should not be interpreted. Of note, the low model quality at the intracellular half of the transmembrane region and in particular of large parts of the intracellular regions do not result from the dimerization &#x2018;experiment&#x2019;, but are also seen in the isolated Na<sub>V</sub>1.5 model, available from the Alphafold database. The reason for the low pLDDT scores are unclear, but are reflected in the missing cryo-EM densities in these regions.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Comparison of Nav1.5 cryo-EM and Alphafold structures. Identification of putative disease hotspots at the DII_S1- TM1 interface. <bold>(A)</bold> Representation of domains II and III of the Na<sub>V</sub>1.5 AlphaFold model in side view; <bold>(B)</bold>, isolated voltage sensor of domain II, with the charge carrying residues in S4, conserved acidic residues and the hydrophobic constriction site (HCS) are shown as sticks.</p>
</caption>
<graphic xlink:href="fphys-15-1362964-g003.tif"/>
</fig>
</sec>
<sec id="s2-3">
<title>2.3 Trafficking-deficient variant hotspots at the Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 interface</title>
<p>Given the experimentally documented relevance of disease-linked mutations to the function of the macromolecular complex (<xref ref-type="bibr" rid="B29">Ponce-Balbuena et al., 2018</xref>), structural mapping of disease-associated missense and deletion mutations was performed. <xref ref-type="table" rid="T2">Table 2</xref> provides an overview of all missense variations identified in the DII-S1-TM1 interface. As shown in <xref ref-type="fig" rid="F3">Figure 3</xref>, six missense mutations (A735&#xa0;V/E and T731I in Nav1.5; C101R, V93I, L94P, and R82W/Q) and one deletion (del S95-F98) were positioned in the predicted binding interface. In particular, the C101R mutation led to trafficking defects (<xref ref-type="bibr" rid="B2">Ballester et al., 2006</xref>). Clinically, this mutation presents with a phenotype of life-threatening events associated with polymorphic ventricular tachycardia (<xref ref-type="bibr" rid="B3">Chun et al., 2004</xref>), which requires treatment with an implantable cardioverter-defibrillator. Since previous work by the Jalife lab (<xref ref-type="bibr" rid="B29">Ponce-Balbuena et al., 2018</xref>) revealed that K<sub>IR</sub>2.1 mutants could negatively influence Na<sub>V</sub>1.5, experimentally testing this effect for C101R is essential. Structurally, arginine side chains possibly play a disruptive role at the protein-protein interface. Similarly, L94P has been shown to negatively affect plasma membrane trafficking, leading to a reduction in the number of functional channels on the cell surface (<xref ref-type="bibr" rid="B34">Takeda et al., 2013</xref>). Co-expression with wild-type subunits rescued channel trafficking, suggesting a non-dominant effect of this mutation. Similarly, an in-frame deletion, del S95-F98, has been shown to negatively impact K<sub>IR</sub>2.1 trafficking; however, it remains trapped in the cytoplasmic domain, even when co-expressed with the wild-type (<xref ref-type="bibr" rid="B28">Plaster et al., 2001</xref>). The deletion of four helical residues in TM1 clearly poses far-reaching effects on the secondary structure and consequently on the putative channel-channel interface.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>details of disease associated hotspot mutations.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Diseasevariant</th>
<th align="center">Channel</th>
<th align="center">Allelic variation</th>
<th align="center">Phenotype</th>
<th align="center">Functional data</th>
<th align="center">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="2" align="center">A735V</td>
<td rowspan="2" align="center">Na<sub>V</sub>1.5</td>
<td rowspan="2" align="center">No data</td>
<td rowspan="2" align="center">BrS</td>
<td rowspan="2" align="center">shifts activation curve to the right, possibly decelerates recovery from inactivation</td>
<td align="center">
<xref ref-type="bibr" rid="B38">Vatta (2002)</xref>
</td>
</tr>
<tr>
<td align="center">
<xref ref-type="bibr" rid="B5">De La Roche et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="center">A735E</td>
<td align="center">Na<sub>V</sub>1.5</td>
<td align="center">No data</td>
<td align="center">BrS, cardio-pulmonary arrest, sinus node dys-function, exercise and epinephrine-induced QT prolongation, supraventricular tachycardia</td>
<td align="center">Loss-of-function</td>
<td align="center">
<xref ref-type="bibr" rid="B45">Glazer et al. (2020)</xref>, <xref ref-type="bibr" rid="B31">Sasaki et al., 2021</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="center">T731I</td>
<td rowspan="2" align="center">Na<sub>V</sub>1.5</td>
<td rowspan="2" align="center">No data</td>
<td rowspan="2" align="center">long QT3 syndrome and an increased risk of arrhythmias</td>
<td rowspan="2" align="center">No data</td>
<td align="center">
<xref ref-type="bibr" rid="B46">Kapplinger et al. (2009)</xref>
</td>
</tr>
<tr>
<td align="center">
<xref ref-type="bibr" rid="B25">Pan et al. (2021)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="center">C101R</td>
<td rowspan="2" align="center">K<sub>IR</sub>2.1</td>
<td rowspan="2" align="center">heterozygous, dominant negative</td>
<td rowspan="2" align="center">polymorphic ventricular tachycardia</td>
<td rowspan="2" align="center">trafficking-defective; complete loss of channel function, when expressed in oocytes</td>
<td align="center">
<xref ref-type="bibr" rid="B3">Chun et al. (2004)</xref>
</td>
</tr>
<tr>
<td align="center">
<xref ref-type="bibr" rid="B2">Ballester et al. (2006)</xref>
</td>
</tr>
<tr>
<td align="center">Del S95-F98</td>
<td align="center">K<sub>IR</sub>2.1</td>
<td align="center">No data</td>
<td align="center">ATS1</td>
<td align="center">Trafficking defective, dominant negative; impaired protein folding</td>
<td align="center">
<xref ref-type="bibr" rid="B28">Plaster et al. (2001)</xref>
</td>
</tr>
<tr>
<td align="center">L94P</td>
<td align="center">K<sub>IR</sub>2.1</td>
<td align="center">homozygous mutation</td>
<td align="center">ATS1</td>
<td align="center">Trafficking defective, can be rescued, when co-expressing with wild-type subunits</td>
<td align="center">
<xref ref-type="bibr" rid="B34">Takeda et al. (2013)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="center">V93I</td>
<td rowspan="2" align="center">K<sub>IR</sub>2.1</td>
<td rowspan="2" align="center">heterozygous</td>
<td rowspan="2" align="center">familial atrial fibrillation, long QT syndrome</td>
<td rowspan="2" align="center">Gain of function</td>
<td align="center">
<xref ref-type="bibr" rid="B40">Xia et al. (2005)</xref>
</td>
</tr>
<tr>
<td align="center">
<xref ref-type="bibr" rid="B43">Zaklyazminskaya et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="center">R82W</td>
<td align="center">K<sub>IR</sub>2.1</td>
<td align="center">heterozygous, dominant negative effect</td>
<td align="center">ATS1</td>
<td align="center">PIP<sub>2</sub>-dependent gating regulation</td>
<td align="center">
<xref ref-type="bibr" rid="B6">Eckhardt et al. (2007)</xref>
</td>
</tr>
<tr>
<td align="center">R82Q</td>
<td align="center">K<sub>IR</sub>2.1</td>
<td align="center">heterozygous, dominant negative effect</td>
<td align="center">ATS1</td>
<td align="center">PIP<sub>2</sub>-dependent gating regulation</td>
<td align="center">
<xref ref-type="bibr" rid="B6">Eckhardt et al. (2007)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Mutation V93I is associated with familial atrial fibrillation and can lead to increased channel activity (<xref ref-type="bibr" rid="B40">Xia et al., 2005</xref>). <italic>In vitro</italic> analysis of channel function revealed a gain-of-function for this variant (<xref ref-type="bibr" rid="B40">Xia et al., 2005</xref>; <xref ref-type="bibr" rid="B43">Zaklyazminskaya et al., 2022</xref>). A study of Russian patients with this variant revealed a surprising phenotype without any signs of ATS1 or mild but evident QTc prolongation (<xref ref-type="bibr" rid="B43">Zaklyazminskaya et al., 2022</xref>). Thus, the clinical significance of this variant remains unclear; however, it is classified as a potential proarrhythmogenic risk factor. A structural interpretation based on the putative Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex suggests increased stability of the interface due to V93I, which fits the experimentally observed increase in channel activity. Explaining the reason behind the alterations in channel function following replacement of the valine side chain with the bulkier isoleucine side chain, based on the isolated K<sub>IR</sub>2.1 structure, remains challenging. In the non-complexed state, this residue faces toward the lipid membrane, and unless currently unknown specific lipid interactions occur at this site, the impact of isoleucine should be negligible. Further, position V93 is not a highly conserved residue, and several species possess isoleucine at that position (<xref ref-type="bibr" rid="B12">Houtman et al., 2014</xref>). Further studies on the importance of this putative disease variant are required to clarify its role.</p>
<p>The missense variants of R82W/Q have been implicated in PIP<sub>2</sub>-dependent gating regulation (<xref ref-type="bibr" rid="B6">Eckhardt et al., 2007</xref>). Thus, mechanical dissection of mutant effects requires structural determination of the channel complex in multiple functional states. This requires thorough experimental validation of the predicted complex, which is beyond the scope of the current study.</p>
<p>The missense variant A735V in Na<sub>V</sub>1.5 has been reported to shift the activation curve to the right and possibly decelerate recovery from inactivation. No obvious changes in channel expression or membrane insertion were observed. Furthermore, this mutant has been shown to reduce the upstroke velocity of action potentials in hiPSC-CMs (<xref ref-type="bibr" rid="B5">De La Roche et al., 2019</xref>). Phenotypically, the A735V mutation is associated with Brugada syndrome and can cause malignant arrhythmias and ventricular fibrillation, leading to sudden cardiac death (<xref ref-type="bibr" rid="B38">Vatta, 2002</xref>). On the contrary, the phenotypic manifestation of the A735E mutant is very complex, poorly understood, and difficult to explain, when considering only the effects of Na<sub>V</sub>1.5 (<xref ref-type="bibr" rid="B31">Sasaki et al., 2021</xref>). Thus, <xref ref-type="bibr" rid="B31">Sasaki et al. (2021)</xref> suggested that this mutation might affect other functionally or structurally associated proteins. Na<sub>V</sub>1.5 interacts with a multitude of different auxiliary proteins, associated proteins, anchoring proteins, &#x3b2;-subunits, scaffolding proteins, adapter proteins, and regulatory proteins, a group of which harbor disease-causing mutations that have been shown to affect I<sub>Na</sub> (<xref ref-type="bibr" rid="B19">Kyle and Makielski, 2014</xref>). Thus, the K<sub>IR</sub>2.1 interaction may be speculated to play a crucial role here. However, functional studies in this area are lacking. Therefore, testing for disease mutations may be informative in the context of the macromolecular Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex. An interesting hypothesis derived from the modeled complex suggests that the formation of a salt bridge between disease variants A735E and C101R might be possible. This could potentially stabilize the trafficking of C101R and positively influence the missense variant A735E. Such analyses would not only help to test and validate the predicted interface, but also provide crucial information on the complex mechanism of inherited cardiac diseases resulting from defects in Na<sub>V</sub>1.5 and K<sub>IR</sub>2.1. Mutation T731I is associated with Long QT3 syndrome and an increased risk of arrhythmias (<xref ref-type="bibr" rid="B25">Pan et al., 2021</xref>). However, no further details regarding this mutation are available in the literature.</p>
<p>In summary, three of four ATS1 mutations predicted interface-induced trafficking defects. This is interesting because experimental studies have revealed the importance of the macromolecular complex for trafficking (<xref ref-type="bibr" rid="B29">Ponce-Balbuena et al., 2018</xref>). Since the impairment of K<sub>IR</sub>2.1 trafficking in cardiomyocytes affects Na<sub>V</sub>1.5 trafficking and <italic>vice versa</italic>, studying the mechanisms of these inheritable disease mutants is crucial in the context of both interaction partners.</p>
</sec>
<sec id="s2-4">
<title>2.4 Functional implications resulting from the proposed Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 model</title>
<p>Modeling predictions suggest that the main role of the macromolecular Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex is to stabilize during forward trafficking, interacting with a large interface as the complex pre-assembles early (<xref ref-type="bibr" rid="B29">Ponce-Balbuena et al., 2018</xref>). In line with this, the disruption of trafficking by one partner has been shown to affect trafficking by the other. However, both channels interact through common partners, such as scaffolding, anchoring, adaptor, and regulatory proteins (<xref ref-type="bibr" rid="B26">Park et al., 2020</xref>), whose atomic interactions cannot be reliably modeled with current programs.</p>
<p>Evidence from experimental studies suggest that a subpopulation of Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 channels can physically interact when bound to the plasma membrane. First, both channels travel through similar retrograde trafficking (endosome-to-Golgi transport) routes. Additionally, co-expression of the two channels resulted in an increase in Na<sub>V</sub>1.5 density. Moreover, both channels have been shown to co-immunoprecipitate in both the forward and reverse co-immunoprecipitation reactions (<xref ref-type="bibr" rid="B29">Ponce-Balbuena et al., 2018</xref>). Independent studies by Eckhardt and Jalife have demonstrated that K<sub>IR</sub>2.1 and Na<sub>V</sub>1.5, colocalize in ventricular myocytes in humans, rats, and mice (<xref ref-type="bibr" rid="B22">Milstein et al., 2012</xref>; Vaidyanathan et al., 2018).</p>
<p>Based on the predicted physical interaction models presented here, the gating dynamics of both channels clearly influence physical interactions. Relevant interface changes need to be addressed in future experimental studies, such as crosslinking, to confirm the predicted tight physical interaction of the macromolecular Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex at the plasma membrane.</p>
<p>Tighter control of the resting membrane potential and excitability in the ventricles may be possible through strictly and simultaneously regulating the expression of these two channels and their physical contact. This is beneficial in preventing fibrillating arrhythmias (<xref ref-type="bibr" rid="B35">Utrilla et al., 2017</xref>). Given the close contact between the voltage domains of Na<sub>V</sub>1.5 and TM1 of K<sub>IR</sub>2.1 (<xref ref-type="fig" rid="F1">Figures 1D&#x2013;F</xref>), voltage-dependent structural changes from the VSD of Na<sub>V</sub>1.5 might also be transmitted to the K<sub>IR</sub>2.1 pore. Sigg, Chang, and Shieh (<xref ref-type="bibr" rid="B32">Sigg et al., 2018</xref>) suggested the presence of an unknown voltage sensor in K<sub>IR</sub>2.1, when studied in the absence of native intracellular blockers, such as Mg<sup>2&#x2b;</sup> and polyamines. Their study suggested that an unknown voltage sensor communicating allosterically with the pore gate best explains the weak inward rectification in the K<sub>IR</sub>2.1 channels observed. Furthermore, the authors propose that this voltage sensor stabilizes the closure of the pore gate with a coupling factor of &#x223c;31. Based on the current modeling predictions, it is tempting to speculate that the unknown voltage sensor might actually be located on Na<sub>V</sub>1.5. This hypothesis would require <italic>Xenopus laevis</italic> oocytes, which were used as the measuring system, to contain native sodium currents, similar enough to form macromolecular complexes with the injected K<sub>IR</sub>2.1 channels. A BLAST search of the human Na<sub>V</sub>1.5 channel identified a protein sequence in <italic>Xenopus laevis</italic> with approximately 70% sequence identity and almost 80% sequence similarity. However, further studies are required to test this hypothesis.</p>
<p>A recent high-speed atomic force microscopy study of the bacterial voltage-dependent Na<sub>v</sub>Ab channel revealed that VSDs can dissociate from the pore in the resting state and dimerize to form cross-links between channels (<xref ref-type="bibr" rid="B33">Sumino et al., 2023</xref>). In the proposed tight interaction model between Na<sub>V</sub>1.5 and K<sub>IR</sub>2.1, the dissociation of the VSDs is unlikely. It can be expected, that the dynamics of the predicted Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex are different from those of the individual isolated channels.</p>
<p>While most experimentally resolved structures of Na<sub>V</sub> channels display voltage sensors in the &#x201c;up-state&#x201d; (activated), a recent 2.7-&#xc5; resolution Na<sub>V</sub>1.7 structure was captured with one VSD in a completely deactivated (down) state. Voltage-dependent structural changes involve a combination of helix unwinding and spiral sliding of helix S4, and a rotation of the entire VSD domain of approximately 20&#xb0; (<xref ref-type="bibr" rid="B13">Huang et al., 2022</xref>). Although S4, is not involved in the PPI, and movements of S4 are unlikely to influence the Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 interface (<xref ref-type="fig" rid="F1">Figure 1</xref>), rotation of the whole VSD could have a significant impact.</p>
<p>Nature must have designed this subpopulation of Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 channelosomes for some unique biological advantage(s); however, much research is needed to fully understand their specific biological roles and differences to potentially oligomerized Na<sub>V</sub>1.5 channels (reviewed in (<xref ref-type="bibr" rid="B14">Iamshanova et al., 2023</xref>).</p>
<p>Interestingly, sodium ions directly affect K<sub>IR</sub>2.1 function. External Na<sup>&#x2b;</sup> acts as a competitive inhibitor of K<sup>&#x2b;</sup> conductance through K<sub>IR</sub>2.1, which is physiologically relevant under certain pathological conditions. Specifically, this may increase outward K<sup>&#x2b;</sup> efflux through K<sub>IR</sub>2 channels under medical conditions, concomitant with severe hyponatremia (<xref ref-type="bibr" rid="B16">Ishihara, 2018</xref>).</p>
<p>In summary, the current study revealed that tight physical interactions are likely. In fact, modeling predictions suggest a large interface area (&#x3e;3600&#xa0;&#xc5;<sup>2</sup>) with a favorable &#x201c;binding energy,&#x201d; consistent with other PPIs. More importantly, the interface was independently predicted using three different programs, supporting the validity of the prediction. Finally, atomic insights into the Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 complex enable interesting structural interpretations of disease-causing missense variants in both channels. In fact, mutations, such as V93I (K<sub>IR</sub>2.1, <xref ref-type="fig" rid="F3">Figure 3</xref>), are difficult to rationalize in the absence of a tightly bound Na<sub>V</sub>1.5 channel.</p>
</sec>
<sec id="s2-5">
<title>2.5 Limitations of the study</title>
<p>Further studies are required in this exciting area of research. The validity of the <italic>in silico</italic> model needs to be thoroughly tested. The PPI models presented herein have not been refined, which would optimally require extensive molecular dynamics (MD) simulations, which will be done in future studies. Further, <xref ref-type="fig" rid="F4">Figure 4</xref> highlights a disease hotspot, but the mutants have not been modeled and their interactions investigated. This also would require MD refinement of the PPIs and preferably extensive side-chain resampling by simulations, which is beyond the scope of the current study. Further, experiment validation is necessary, for example, via cross-linking studies, for which the current study provides crucial starting points. The current state-of-the-art computational protein-protein interaction methods still perform rather poorly in predicting large macromolecular protein complexes. One particular limitation is the lack of 3D coordinates for large intracellular domains and interaction partners. This prevented us from modeling further interaction partners of much larger macromolecular complexes (<xref ref-type="bibr" rid="B29">Ponce-Balbuena et al., 2018</xref>). Unfortunately, current <italic>ab initio</italic> prediction methods, such as AlphaFold, while performing remarkably well on core regions of proteins, are not yet able to reliably predict intrinsically disordered regions or those that fold into transient 3D structures upon interaction with other binding partners.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Representation of the consensus interface between DII-S1 (Na<sub>V</sub>1.5) and TM1 (K<sub>IR</sub>2.1) of the ClusPro model. All residues with atoms within 6&#xa0;&#xc5; of the interface are shown as sticks. Disease-linked missense variants are shown as spheres, colored in green for Na<sub>V</sub>1.5 and in wheat for K<sub>IR</sub>2.1. The disease-linked deletion delS95-F98 in Kir2.1 is colored in red.</p>
</caption>
<graphic xlink:href="fphys-15-1362964-g004.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="methods" id="s3">
<title>3 Methods</title>
<sec id="s3-1">
<title>3.1 Protein-protein docking</title>
<p>Interactions between Na<sub>V</sub>1.5 (pdb: 6LQA) and K<sub>IR</sub>2.1 (pdb: 7ZDZ) were probed using the Fast Rotational Docking Program (FRODOCK) (<xref ref-type="bibr" rid="B9">Garzon et al., 2009</xref>), ClusPro2.0 (<xref ref-type="bibr" rid="B18">Kozakov et al., 2017</xref>), and AlpaFold-Multimer v3 (<xref ref-type="bibr" rid="B7">Evans et al., 2021</xref>). FRODOCK uses the rigid-body orientational sampling of a ligand molecule with respect to a fixed receptor molecule. It combines the projection of the interaction terms into 3D grid-based potentials and binding energies during complex formation. The binding energy was approximated as a correlation function consisting of van der Waals, electrostatic, and desolvation potential terms. Interaction energy minima were obtained through a fast and exhaustive rotational docking search combined with translational scanning. The program was obtained from <ext-link ext-link-type="uri" xlink:href="https://chaconlab.org/modeling/frodock/">https://chaconlab.org/modeling/frodock/</ext-link>. The poses were visually filtered based on their relative orientations towards each other. The relative orientation of the membrane proteins in the membrane enabled a good discrimination between plausible and implausible poses. Positions with flipped membrane orientations of the two channels with respect to each other, or with one channel interacting with the cytoplasmic or extracellular regions with the transmembrane core of the other channel, were excluded from further analysis.</p>
<p>With FRODOCK 5 poses fulfilled the proper membrane orientation criterion and were further inspected. From these, 3 poses where at the same interface (between DII and III), with &#x223c;2&#x2013;3&#xa0;&#xc5; shifts in their relative orientation (see <xref ref-type="sec" rid="s9">Supplementary Figure S4A</xref>). The pose with the largest number of contacts (as assessed with Prodigy) was chosen and shown in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<p>The second rigid-body docking program was ClusPro v2.0 (<xref ref-type="bibr" rid="B18">Kozakov et al., 2017</xref>). It uses Piper, which is a fast Fourier transform program developed by the Vajda lab for a rigid-body global search, and employs pairwise interaction potentials. The program provides 1,000 low-energy results to the clustering program ClusPro, which then attempts to find the native site based on the underlying assumption that it will have a wide free-energy attractor with the largest number of results. The program was accessed through its web server <ext-link ext-link-type="uri" xlink:href="https://cluspro.org/login.php">https://cluspro.org/login.php</ext-link>. Similar visual filtering of poses as above was performed, and the resulting five best poses were analyzed in detail. Two poses were found at the same interface (between DII and III), while at all other interfaces only one pose was found (see <xref ref-type="sec" rid="s9">Supplementary Figure S4B</xref>). The pose with the larger number of contacts (as assessed with Prodigy) was chosen and shown in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<p>AlpaFold-Multimer v3 uses multiple sequence alignments (MSA) as inputs to predict the structure of protein complexes. For heteromultimers, as is the case for the Na<sub>V</sub>1.5-K<sub>IR</sub>2.1 (five independent subunits), it leverages both MSAunpaired and MSApaired as inputs. Different parameters were tested and the best results were obtained using the following parameters: mmsequs2_uniref_env, no-template mode; number of ensembles: three; number of recycles: ten; pair mode: paired; recycling early stop tolerance: 0.5; and training mode: no. Only the best of the five models obtained using these parameters was further analyzed. The model-predicted pLDDT (predicted local distance difference test) score per residue is shown in <xref ref-type="sec" rid="s9">Supplementary Figure S2</xref>. The mean pLDDT score was 78.29 with an iPTM (average quality of the all interfaces of the complex) score of 0.89.</p>
<p>
<xref ref-type="table" rid="T3">Table 3</xref> provides an overview of the different parameters used for PPI docking by ClusPro, FRODOCK and AlphaFold multimer.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Overview of parameters used for PPI docking.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">ClusPro</th>
<th align="left">FRODOCK</th>
<th align="left">AlphaFold_multimer_v3</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="8" align="left">All heteroatoms including small molecule ligands, lipids and ions were removed from the protein structures before docking. Receptor definition: Na<sub>V</sub>1.5 &#x3b1;-subunit (pdb: 6LQA); Ligand definition: K<sub>IR</sub>2.1 (pdb: 7ZDZ), no advanced options nor restraints were used to bias docking</td>
<td rowspan="8" align="left">All heteroatoms including small molecule ligands, lipids and ions were removed from the protein structures before docking. Receptor definition: Na<sub>V</sub>1.5 &#x3b1;-subunit (pdb: 6LQA), all heteroatoms (small molecule ligand and lipids) were removed; Ligand definition: K<sub>IR</sub>2.1 (pdb: 7ZDZ), no advanced options nor restraints were used to bias docking</td>
<td align="left">The target sequences were obtained from Uniprot, codes: Q14524-1 (SCN5A_HUMAN) including residues 1,187&#x2013;1928 and P63252 &#xb7; KCNJ2_HUMAN, including residues 45&#x2013;387</td>
</tr>
<tr>
<td align="left">Model type was set to multimer_v3</td>
</tr>
<tr>
<td align="left">Template mode: no</td>
</tr>
<tr>
<td align="left">Multisequence database used: mmsequs2_uniref_env</td>
</tr>
<tr>
<td align="left">Pair mode: paired number of ensembles: three</td>
</tr>
<tr>
<td align="left">number of recycles: ten</td>
</tr>
<tr>
<td align="left">recycling early stop tolerance: 0.5</td>
</tr>
<tr>
<td align="left">training mode: no</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-2">
<title>3.2 Interface analysis</title>
<p>Interface analysis was performed using the PISA-PDBe web server (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/msd-srv/prot_int/cgi-bin/piserver">https://www.ebi.ac.uk/msd-srv/prot_int/cgi-bin/piserver</ext-link>) and Prodigy (<xref ref-type="bibr" rid="B42">Xue et al., 2016</xref>) (<ext-link ext-link-type="uri" xlink:href="https://bianca.science.uu.nl/prodigy/">https://bianca.science.uu.nl/prodigy/</ext-link>). Both web servers enable a quick analysis of protein-protein interfaces, including the number of contacts within a certain cutoff, and simplified binding affinity predictions, which do not reflect the true energies of the complexes but are useful in quickly ranking model poses obtained from different docking programs.</p>
</sec>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s4">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s9">Supplementary Material</xref>, further inquiries can be directed to the corresponding author. The models presented in the study are publicly available. This data can be found here: <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/records/10677482">https://zenodo.org/records/10677482</ext-link>.</p>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>AS-W: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing&#x2013;original draft.</p>
</sec>
<sec sec-type="funding-information" id="s6">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the doctoral program &#x201c;Molecular drug targets&#x201d; W1232 of the Austrian Science Fund (FWF; <ext-link ext-link-type="uri" xlink:href="http://www.fwf.ac.at">http://www.fwf.ac.at</ext-link> and from the Hochschuljubil&#xe4;umsstiftung der Stadt Wien (H-269241/2020).</p>
</sec>
<ack>
<p>The author thanks Eva-Maria Zangerl-Plessl for helpful insights regarding the manuscript. We would like to thank Editage (<ext-link ext-link-type="uri" xlink:href="http://www.editage.com/">www.editage.com</ext-link>) for English language editing.</p>
</ack>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of interest</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s9">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2024.1362964/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphys.2024.1362964/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abriel</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Roles and regulation of the cardiac sodium channel Nav1.5: recent insights from experimental studies</article-title>. <source>Cardiovasc. Res.</source> <volume>76</volume> (<issue>3</issue>), <fpage>381</fpage>&#x2013;<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2007.07.019</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ballester</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Woodrow Benson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>I. H.</given-names>
</name>
<name>
<surname>Mathews</surname>
<given-names>K. D.</given-names>
</name>
<name>
<surname>Vanoye</surname>
<given-names>C. G.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Trafficking-competent and trafficking-defectiveKCNJ2 mutations in andersen syndrome</article-title>. <source>Hum. Mutat.</source> <volume>27</volume> (<issue>4</issue>), <fpage>388</fpage>. <pub-id pub-id-type="doi">10.1002/humu.9418</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chun</surname>
<given-names>T. U. H.</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Macdonald</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gregor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ballester</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vanoye</surname>
<given-names>C. G.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Polymorphic ventricular tachycardia and KCNJ2 mutations</article-title>. <source>Heart rhythm.</source> <volume>1</volume> (<issue>2</issue>), <fpage>235</fpage>&#x2013;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2004.02.017</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cantwell</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zorn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Diomedes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Logothetis</surname>
</name>
</person-group> (<year>2021</year>). &#x201c;<article-title>Kir Channel molecular Physiology, pharmacology, and therapeutic implications</article-title>,&#x201d; in <source>Pharmacology of potassium channels</source> Editors <person-group person-group-type="editor">
<name>
<surname>Gamper</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K W</given-names>
</name>
</person-group> (<publisher-loc>Cham</publisher-loc>: <publisher-name>Springer International Publishing</publisher-name>), <fpage>277</fpage>. <pub-id pub-id-type="doi">10.1007/164_2021_501</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De La Roche</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Angsutararux</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kempf</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Janan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bolesani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Thiemann</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of NaV1.5 sodium channels</article-title>. <source>Sci. Rep.</source> <volume>9</volume> (<issue>1</issue>), <fpage>11173</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-47632-4</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckhardt</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Farley</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ruwaldt</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hammill</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tester</surname>
<given-names>D. J.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>KCNJ2 mutations in arrhythmia patients referred for lqt testing: a mutation T305A with novel effect on rectification properties</article-title>. <source>Heart rhythm.</source> <volume>4</volume> (<issue>3</issue>), <fpage>323</fpage>&#x2013;<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2006.10.025</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>O&#x2019;Neill</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Antropova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Senior</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Protein complex prediction with AlphaFold-multimer</article-title>. <source>Prepr. Bioinforma.</source> <pub-id pub-id-type="doi">10.1101/2021.10.04.463034</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>C. A. H.</given-names>
</name>
<name>
<surname>Zuniga</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fagnen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kugler</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Rosa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>P&#xe9;hau-Arnaudet</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Cryo&#x2013;electron microscopy unveils unique structural features of the human Kir21 channel</article-title>. <source>Sci. Adv.</source> <volume>8</volume> (<issue>38</issue>), <fpage>eabq8489</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abq8489</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garzon</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Lop&#xe9;z-Blanco</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Pons</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Abagyan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fernandez-Recio</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>FRODOCK: a new approach for fast rotational protein&#x2013;protein docking</article-title>. <source>Bioinformatics</source> <volume>25</volume> (<issue>19</issue>), <fpage>2544</fpage>&#x2013;<lpage>2551</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp447</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glazer</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Muhammad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kalash</surname>
<given-names>O. R.</given-names>
</name>
<name>
<surname>O&#x2019;Neill</surname>
<given-names>M. J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>High-throughput reclassification of SCN5A variants</article-title>. <source>Am. J. Hum. Genet.</source> <volume>107</volume> (<issue>1</issue>), <fpage>111</fpage>&#x2013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2020.05.015</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hager</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>McAtee</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Lesko</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>O&#x2019;Donnell</surname>
<given-names>A. F.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Inwardly rectifying potassium channel Kir2.1 and its &#x201c;kir-ious&#x201d; regulation by protein trafficking and roles in development and disease</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>9</volume> (<issue>February</issue>), <fpage>796136</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.796136</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hibino</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Inanobe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Furutani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Findlay</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kurachi</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Inwardly rectifying potassium channels: their structure, function, and physiological roles</article-title>. <source>Physiol. Rev.</source> <volume>90</volume> (<issue>1</issue>), <fpage>291</fpage>&#x2013;<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00021.2009</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houtman</surname>
<given-names>M. J. C.</given-names>
</name>
<name>
<surname>Korte</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Ji</given-names>
</name>
<name>
<surname>Kok</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Marcel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Van Der Heyden</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Insights in KIR2.1 channel structure and function by an evolutionary approach; cloning and functional characterization of the first reptilian inward rectifier channel KIR2.1, derived from the California kingsnake (Lampropeltis getula californiae)</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>452</volume> (<issue>4</issue>), <fpage>992</fpage>&#x2013;<lpage>997</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2014.09.031</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Unwinding and spiral sliding of S4 and domain rotation of VSD during the electromechanical coupling in Na <sub>v</sub> 1.7</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>119</volume> (<issue>33</issue>), <fpage>e2209164119</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2209164119</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iamshanova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Rougier</surname>
<given-names>J.-S.</given-names>
</name>
<name>
<surname>Abriel</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Exploring the oligomerization of Na <sub>v</sub> 1.5 and its implication for the dominant-negative effect</article-title>. <source>Bioelectricity</source> <volume>5</volume> (<issue>4</issue>), <fpage>279</fpage>&#x2013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1089/bioe.2023.0014</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibarra</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Morley</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Delmar</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Dynamics of the inward rectifier K&#x2b; current during the action potential of Guinea pig ventricular myocytes</article-title>. <source>Biophysical J.</source> <volume>60</volume> (<issue>6</issue>), <fpage>1534</fpage>&#x2013;<lpage>1539</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(91)82187-7</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishihara</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>External K&#x2b; dependence of strong inward rectifier K&#x2b; channel conductance is caused not by K&#x2b; but by competitive pore blockade by external Na</article-title>. <source>J. General Physiology</source> <volume>150</volume> (<issue>7</issue>), <fpage>977</fpage>&#x2013;<lpage>989</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201711936</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tonggu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gamal El-Din</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Lenaeus</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Structure of the cardiac sodium channel</article-title>. <source>Cell</source> <volume>180</volume> (<issue>1</issue>), <fpage>122</fpage>&#x2013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2019.11.041</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapplinger</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Tester</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Salisbury</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Harris-Kerr</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pollevick</surname>
<given-names>G. D.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION&#x00AE; long QT syndrome genetic test</article-title>. <source>Heart Rhythm.</source> <volume>6</volume> (<issue>9</issue>), <fpage>1297</fpage>&#x2013;<lpage>1303</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2009.05.021</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kozakov</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Padhorny</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yueh</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>The ClusPro web server for protein&#x2013;protein docking</article-title>. <source>Nat. Protoc.</source> <volume>12</volume> (<issue>2</issue>), <fpage>255</fpage>&#x2013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2016.169</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kyle</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Makielski</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Diseases caused by mutations in Nav1.5 interacting proteins</article-title>. <source>Card. Electrophysiol. Clin.</source> <volume>6</volume> (<issue>4</issue>), <fpage>797</fpage>&#x2013;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccep.2014.08.007</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.-J.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Heyman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stary-Weinzinger</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>ColinNichols</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Structural basis of control of inward rectifier Kir2 channel gating by bulk anionic phospholipids</article-title>. <source>J. General Physiology</source> <volume>148</volume> (<issue>3</issue>), <fpage>227</fpage>&#x2013;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201611616</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Structure of human Na <sub>v</sub> 1.5 reveals the fast inactivation-related segments as a mutational hotspot for the Long QT syndrome</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>118</volume> (<issue>11</issue>), <fpage>e2100069118</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2100069118</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milstein</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Daniela Ponce</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Justus</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Anumonwo</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Furspan</surname>
<given-names>P. B.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmia</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>109</volume> (<issue>31</issue>), <fpage>E2134</fpage>&#x2013;<lpage>E2143</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1109370109</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno-Manuel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Isabel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lilian</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vera-Pedrosa</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Miguel Cruz</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Carrascoso</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Molecular stratification of arrhythmogenic mechanisms in the andersen tawil syndrome</article-title>. <source>Cardiovasc. Res.</source> <volume>119</volume> (<issue>4</issue>), <fpage>919</fpage>&#x2013;<lpage>932</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvac118</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noreng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Payandeh</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Structural pharmacology of voltage-gated sodium channels</article-title>. <source>J. Mol. Biol.</source> <volume>433</volume> (<issue>17</issue>), <fpage>166967</fpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2021.166967</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Comparative structural analysis of human Na <sub>v</sub> 1.1 and Na <sub>v</sub> 1.5 reveals mutational hotspots for sodium channelopathies</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>118</volume> (<issue>11</issue>), <fpage>e2100066118</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2100066118</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>S.-S.</given-names>
</name>
<name>
<surname>Ponce-Balbuena</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kuick</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Guerrero-Serna</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mellacheruvu</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Kir2.1 interactome mapping uncovers PKP4 as a modulator of the kir2.1-regulated inward rectifier potassium currents</article-title>. <source>Mol. Cell. Proteomics</source> <volume>19</volume> (<issue>9</issue>), <fpage>1436</fpage>&#x2013;<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.RA120.002071</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>P&#xe9;rez-Hern&#xe1;ndez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Matamoros</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alfayate</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nieto-Mar&#xed;n</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Utrilla</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Tinaquero</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Brugada syndrome trafficking&#x2013;defective Nav1.5 channels can trap cardiac kir2.1/2.2 channels</article-title>. <source>JCI Insight</source> <volume>3</volume> (<issue>18</issue>), <fpage>e96291</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.96291</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plaster</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Tawil</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tristani-Firouzi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Can&#xfa;n</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bendahhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tsunoda</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of andersen&#x2019;s syndrome</article-title>. <source>Cell</source> <volume>105</volume> (<issue>4</issue>), <fpage>511</fpage>&#x2013;<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00342-7</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponce-Balbuena</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Guerrero-Serna</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Valdivia</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Caballero</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Javier Diez-Guerra</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>R. J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Cardiac Kir2.1 and Na <sub>V</sub> 1.5 channels traffic together to the sarcolemma to control excitability</article-title>. <source>Circulation Res.</source> <volume>122</volume> (<issue>11</issue>), <fpage>1501</fpage>&#x2013;<lpage>1516</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.311872</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reilly</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Eckhardt</surname>
<given-names>L. L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cardiac potassium inward rectifier Kir2: review of structure, regulation, pharmacology, and arrhythmogenesis</article-title>. <source>Heart rhythm.</source> <volume>18</volume> (<issue>8</issue>), <fpage>1423</fpage>&#x2013;<lpage>1434</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2021.04.008</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sasaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawabata-Iwakawa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Iizuka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dharmawan</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Multiple arrhythmic and cardiomyopathic phenotypes associated with an SCN5A A735E mutation</article-title>. <source>J. Electrocardiol.</source> <volume>65</volume> (<issue>March</issue>), <fpage>122</fpage>&#x2013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.jelectrocard.2021.01.019</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sigg</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.-K.</given-names>
</name>
<name>
<surname>Shieh</surname>
<given-names>R.-C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Linkage analysis reveals allosteric coupling in Kir21 channels</article-title>. <source>J. General Physiology</source> <volume>150</volume> (<issue>11</issue>), <fpage>1541</fpage>&#x2013;<lpage>1553</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201812127</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sumino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sumikama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Irie</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Voltage sensors of a Na&#x2b; channel dissociate from the pore domain and form inter-channel dimers in the resting state</article-title>. <source>Nat. Commun.</source> <volume>14</volume> (<issue>1</issue>), <fpage>7835</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-023-43347-3</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeda</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ueno</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Morino</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ochi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Autosomal recessive andersen-tawil syndrome with a novel mutation L94P in Kir2.1</article-title>. <source>Neurology Clin. Neurosci.</source> <volume>1</volume> (<issue>4</issue>), <fpage>131</fpage>&#x2013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1111/ncn3.38</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Utrilla</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Nieto-Mar&#xed;n</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Alfayate</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tinaquero</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Matamoros</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>P&#xe9;rez-Hern&#xe1;ndez</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Kir2.1-Nav1.5 channel complexes are differently regulated than Kir2.1 and Nav1.5 channels alone</article-title>. <source>Front. Physiology</source> <volume>8</volume> (<issue>November</issue>), <fpage>903</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2017.00903</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaidyanathan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Van Ert</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Haq</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Morotti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Esch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McCune</surname>
<given-names>E. C.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Inward rectifier potassium channels (Kir2.x) and caveolin-3 domain&#x2013;specific interaction: implications for purkinje cell&#x2013;dependent ventricular arrhythmias</article-title>. <source>Circulation Arrhythmia Electrophysiol.</source> <volume>11</volume> (<issue>1</issue>), <fpage>e005800</fpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.117.005800</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vakser</surname>
<given-names>I. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Challenges in protein docking</article-title>. <source>Curr. Opin. Struct. Biol.</source> <volume>64</volume>, <fpage>160</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2020.07.001</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vatta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dumaine</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Varghese</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Aihara</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome</article-title>. <source>Hum. Mol. Genet.</source> <volume>11</volume> (<issue>3</issue>), <fpage>337</fpage>&#x2013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/11.3.337</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vreven</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Moal</surname>
<given-names>I. H.</given-names>
</name>
<name>
<surname>Anna</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>B. G.</given-names>
</name>
<name>
<surname>Kastritis</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Torchala</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Updates to the integrated protein&#x2013;protein interaction benchmarks: docking benchmark version 5 and affinity benchmark version 2</article-title>. <source>J. Mol. Biol.</source> <volume>427</volume> (<issue>19</issue>), <fpage>3031</fpage>&#x2013;<lpage>3041</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2015.07.016</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Bendahhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Larroque</surname>
<given-names>M.-M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>332</volume> (<issue>4</issue>), <fpage>1012</fpage>&#x2013;<lpage>1019</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2005.05.054</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rohou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Arthur</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Tzakoniati</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Structural basis of Nav1.7 inhibition by a gating-modifier spider toxin</article-title>. <source>Cell</source> <volume>176</volume> (<issue>4</issue>), <fpage>702</fpage>&#x2013;<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.12.018</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>Li C.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Kastritis</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Bonvin</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Anna</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>PRODIGY: a web server for predicting the binding affinity of protein&#x2013;protein complexes</article-title>. <source>Bioinformatics</source> <volume>32</volume> (<issue>23</issue>), <fpage>3676</fpage>&#x2013;<lpage>3678</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btw514</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaklyazminskaya</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Polyak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Anna</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sadekova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vera</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kiseleva</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Variable clinical appearance of the Kir2.1 rare variants in Russian patients with Long QT syndrome</article-title>. <source>Genes</source> <volume>13</volume> (<issue>4</issue>), <fpage>559</fpage>. <pub-id pub-id-type="doi">10.3390/genes13040559</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zangerl-Plessl</surname>
<given-names>Z. M.</given-names>
</name>
<name>
<surname>Colin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.-J.</given-names>
</name>
<name>
<surname>Maksaev</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bernsteiner</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Atomistic basis of opening and conduction in mammalian inward rectifier potassium (Kir2.2) channels</article-title>. <source>J. General Physiology</source> <volume>152</volume>, <fpage>e201912422</fpage>. <pub-id pub-id-type="doi">10.1085/jgp.201912422</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>